Continuous disclosure rules allow a company to hold onto results if the data is incomplete. The wording in this announcement alludes pretty heavily towards this being their reason. They will sit on the Payne assays until they have all of them.
The options are a non event. They've been trading at 0.1 cents for a long while, if trading at all. That means for a long while 2000 dollars worth of options would make you the largest holder. Most of the big options holders would have received them free in the last cap raise. With an exercise price of 13 cents I think it's reasonable of the company to let them expire with the share price being 5-6 cents recently.
I hold a bunch and for me to exercise them the share price would have to be well above 13 cents to make it all worthwhile. For the sake of some options that cost me next to nothing, I'd rather lose that money and buy the heads as I please.
Continuous disclosure rules allow a company to hold onto results...
Add to My Watchlist
What is My Watchlist?
